Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Frontiers in Immunology
|
May 19, 2023
Corrigendum: Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature
Ambra Natalini, Sonia Simonetti, Gabriele Favaretto, et al.
Frontiers in Immunology
|
March 3, 2023
Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature
Ambra Natalini, Sonia Simonetti, Gabriele Favaretto, et al.
Oncogene
|
January 9, 2021
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions
Francesco Pantano, Martine Croset, Keltouma Driouch, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 4, 2023
Network approach in liquidomics landscape
Daniele Santini, Andrea Botticelli, Antonio Galvano, et al.
Cancers
|
May 28, 2022
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients
Francesco Pantano, Francesca Zalfa, Michele Iuliani, et al.
JCO Precision Oncology
|
December 7, 2020
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study
Francesco Pantano, Paolo Manca, Grazia Armento, et al.
Breast (Edinburgh, Scotland)
|
May 27, 2025
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors
Roberta Scafetta, Marco Donato, Carla Gullotta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study
Roberta Scafetta, Raffaella Troiano, Carla Gullotta, et al.
The Oncologist
|
April 17, 2026
Comparative real-world Progression Free Survival of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Patients with Bone Metastases
Roberta Scafetta, Marco Donato, Carla Gullotta, et al.
European Journal of Immunology
|
December 15, 2021
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Frontiers in Immunology
|
May 19, 2023
Corrigendum: Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature
Ambra Natalini, Sonia Simonetti, Gabriele Favaretto, et al.
Frontiers in Immunology
|
March 3, 2023
Improved memory CD8 T cell response to delayed vaccine boost is associated with a distinct molecular signature
Ambra Natalini, Sonia Simonetti, Gabriele Favaretto, et al.
Oncogene
|
January 9, 2021
Integrin alpha5 in human breast cancer is a mediator of bone metastasis and a therapeutic target for the treatment of osteolytic lesions
Francesco Pantano, Martine Croset, Keltouma Driouch, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
August 4, 2023
Network approach in liquidomics landscape
Daniele Santini, Andrea Botticelli, Antonio Galvano, et al.
Cancers
|
May 28, 2022
Large-Scale Profiling of Extracellular Vesicles Identified miR-625-5p as a Novel Biomarker of Immunotherapy Response in Advanced Non-Small-Cell Lung Cancer Patients
Francesco Pantano, Francesca Zalfa, Michele Iuliani, et al.
JCO Precision Oncology
|
December 7, 2020
Breakthrough Cancer Pain Clinical Features and Differential Opioids Response: A Machine Learning Approach in Patients With Cancer From the IOPS-MS Study
Francesco Pantano, Paolo Manca, Grazia Armento, et al.
Breast (Edinburgh, Scotland)
|
May 27, 2025
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors
Roberta Scafetta, Marco Donato, Carla Gullotta, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study
Roberta Scafetta, Raffaella Troiano, Carla Gullotta, et al.
The Oncologist
|
April 17, 2026
Comparative real-world Progression Free Survival of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Patients with Bone Metastases
Roberta Scafetta, Marco Donato, Carla Gullotta, et al.
European Journal of Immunology
|
December 15, 2021
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Andrea Cossarizza, Hyun-Dong Chang, Andreas Radbruch, et al.
Page
of 3